Navigation Links
NexGen Biomedical, Inc. Provides New Insights Into Jett Travolta's Seizure Related Death

SAN JOSE, Calif., June 12, 2012 /PRNewswire/ -- US patent 8,197,858 issued on June 12, 2012 discloses a previously unknown pathogenesis underlying seizures / epilepsy and migraines and provides novel treatment options for the 50 million seizure patients and 300 million migraine sufferers worldwide.

"We scientifically validated that triggers such as drops in estrogen or testosterone or increases in prostaglandin or Vitamin D synthesis all boost release of calcium ions from bone.  We also validated that boosting extracellular calcium ion levels boosts seizure and migraine risk by 1) depolarizing nerve membranes, 2) increasing calcium channel mediated neurotransmitter release and 3) boosting muscle contractility,"  according to Mark Zamoyski,  NexGen Biomedical, Inc.'s founder and the patent holder.

"Why 50 million people worldwide have low seizures thresholds is not clear, however, the new pathogenesis provides an insight into factors that would increase their risk of having a seizure,"  continued Mark Zamoyski.  "We can begin to understand the perfect storm of risk factors that possibly contributed to 16 year old Jett Travolta's uncontrollable seizure while on a vacation in the Bahamas.  Puberty brings nighttime testosterone surges, followed by daytime drops, which boost calcium ion release from bone.   Sun exposure can boost Vitamin D synthesis to 25 times the RDA and sunburn boosts prostaglandin synthesis, both of which boost release of calcium from bone and hence boost seizure risk.  And those are just some of the risk factors on the list."

"Previously unexplained migraine observations could now also be explained. As an example, one study found 45% of women with menstrual migraines had magnesium deficiency.  The new pathogenesis explanation:  It is known that estrogen levels drop precipitously at the start of menstruation.  That in turn would result in a boost in extracellular calcium levels.   Magnesium is a physiological calcium channel blocker, which would attenuate the calcium channel mediated neurotransmitter release."

"Basically, the science indicates that anything that boosts release of calcium ions from bone boosts seizure and migraine risk and conversely anything that reduces release of calcium ions from bone reduces seizure and migraine risk.  Fortunately, there are existing bone homeostasis drugs that could be easily repurposed to reduce seizure and migraine risk,"  Mark Zamoyski summarized.

More comprehensive data supporting the pathogenesis, and a list of things that increase or decrease release of calcium ions from bone, is provided at

SOURCE NexGen Biomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
2. Elevate Provides Remote Access to Personal Health Records Using
3. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
4. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
7. Endo Announces Resolution of Patent Litigation with Watson Pharmaceuticals Related to Lidoderm®
8. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
9. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
10. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
11. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
Post Your Comments:
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... The ... OSHA Training Institute Education Center headquartered in Northern California, has issued an important ... heat at their worksites. Employers with workers exposed to high temperatures should ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ePAY ... partnership with Connance, a healthcare industry leader providing predictive analytics to optimize ... combine to provide health systems, hospitals and ambulatory surgical centers with dramatic ...
(Date:6/27/2016)... ... 2016 , ... A revolution is underway. Brooklyn-based company, ... for the millions of people who require these medical transport services annually. ... the use of technology. Now, SmartEMS has put forth an industry-changing app that ...
Breaking Medicine News(10 mins):